001     834099
005     20220930130125.0
024 7 _ |2 doi
|a 10.1007/s40336-017-0225-z
024 7 _ |2 ISSN
|a 2281-5872
024 7 _ |2 ISSN
|a 2281-7565
024 7 _ |2 Handle
|a 2128/14771
024 7 _ |2 WOS
|a WOS:000401710600003
037 _ _ |a FZJ-2017-04100
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-Juel1)141877
|a Filss, Christian
|b 0
245 _ _ |a Amino acid PET and MR perfusion imaging in brain tumours
260 _ _ |a Berlin
|b Springer Milan
|c 2017
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1498716571_11468
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a PurposeDespite the excellent capacity of the conventional MRI to image brain tumours, problems remain in answering a number of critical diagnostic questions. To overcome these diagnostic shortcomings, PET using radiolabeled amino acids and perfusion-weighted imaging (PWI) are currently under clinical evaluation. The role of amino acid PET and PWI in different diagnostic challenges in brain tumours is controversial.MethodsBased on the literature and experience of our centres in correlative imaging with PWI and PET using O-(2-[18F]fluoroethyl)-l-tyrosine or 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine, the current role and shortcomings of amino acid PET and PWI in different diagnostic challenges in brain tumours are reviewed. Literature searches were performed on PubMed, and additional literature was retrieved from the reference lists of identified articles. In particular, all studies in which amino acid PET was directly compared with PWI were included.ResultsPWI is more readily available, but requires substantial expertise and is more sensitive to artifacts than amino acid PET. At initial diagnosis, PWI and amino acid PET can help to define a site for biopsy but amino acid PET appears to be more powerful to define the tumor extent. Both methods are helpful to differentiate progression or recurrence from unspecific posttherapeutic changes. Assessment of therapeutic efficacy can be achieved especially with amino acid PET, while the data with PWI are sparse.ConclusionBoth PWI and amino acid PET add valuable diagnostic information to the conventional MRI in the assessment of patients with brain tumours, but further studies are necessary to explore the complementary nature of these two methods.
536 _ _ |0 G:(DE-HGF)POF3-573
|a 573 - Neuroimaging (POF3-573)
|c POF3-573
|f POF III
|x 0
536 _ _ |0 G:(DE-HGF)POF3-572
|a 572 - (Dys-)function and Plasticity (POF3-572)
|c POF3-572
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef
700 1 _ |0 P:(DE-HGF)0
|a Cicone, Francesco
|b 1
700 1 _ |0 P:(DE-Juel1)131794
|a Shah, N. J.
|b 2
700 1 _ |0 P:(DE-Juel1)143792
|a Galldiks, Norbert
|b 3
700 1 _ |0 P:(DE-Juel1)131777
|a Langen, Karl-Josef
|b 4
|e Corresponding author
773 _ _ |0 PERI:(DE-600)2712000-4
|a 10.1007/s40336-017-0225-z
|g Vol. 5, no. 3, p. 209 - 223
|n 3
|p 209 - 223
|t Clinical and translational imaging
|v 5
|x 2281-7565
|y 2017
856 4 _ |u https://juser.fz-juelich.de/record/834099/files/10.1007_s40336-017-0225-z.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/834099/files/10.1007_s40336-017-0225-z.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/834099/files/10.1007_s40336-017-0225-z.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/834099/files/10.1007_s40336-017-0225-z.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/834099/files/10.1007_s40336-017-0225-z.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/834099/files/10.1007_s40336-017-0225-z.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:834099
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)141877
|a Forschungszentrum Jülich
|b 0
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131794
|a Forschungszentrum Jülich
|b 2
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)143792
|a Forschungszentrum Jülich
|b 3
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131777
|a Forschungszentrum Jülich
|b 4
|k FZJ
913 1 _ |0 G:(DE-HGF)POF3-573
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
913 1 _ |0 G:(DE-HGF)POF3-572
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v (Dys-)function and Plasticity
|x 1
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2017
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0199
|2 "StatID
|a Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 0
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 1
920 1 _ |0 I:(DE-82)080010_20140620
|k JARA-BRAIN
|l JARA-BRAIN
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-82)080010_20140620
980 _ _ |a APC
980 1 _ |a APC
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21